Rao, Yiyun
Ahmed, Nabeel
Pritchard, Justin
O’Brien, Edward P.
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (5R21EB026617)
National Institutes of Health (R35-GM124818)
National Science Foundation (ABI-1759860)
Article History
Received: 31 January 2023
Accepted: 5 October 2023
First Online: 7 December 2023
Declarations
:
: Not applicable.
: Not applicable.
: YR has no competing interest. NA has no competing interest. EPO has no competing interest. JRP has ownership interests in Theseus Pharmaceutical and MOMA therapeutics. JRP is a co-founder of Theseus Pharmaceuticals. JRP is a paid consultant for Takeda Pharmaceuticals, Theseus Pharmaceuticals, MOMA therapeutics, and third rock ventures. JRP receives research funding from Theseus Pharmaceuticals.